These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 6559080)

  • 1. [The effect of dopaminergic stimulation and inhibition on the urinary excretion of aldosterone and kallikrein in spontaneously hypertensive rats].
    Minuz P; Gangi F; Degan M; Lechi C; Delva P; Lechi A
    Boll Soc Ital Biol Sper; 1983 Oct; 59(10):1435-41. PubMed ID: 6559080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prepuberal gonadectomy upon aldosterone levels in female and male SHR: interaction between blood pressure and kallikrein kinin system.
    Oddo EM; de Luca Sarobe V; Krmar R; Periz GA; Herrera H; Martín RS; Ibarra FR; Arrizurieta EE
    Clin Exp Hypertens; 2006 Feb; 28(2):157-70. PubMed ID: 16546841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Decrease in urinary excretion of active kallikrein in conscious young and adult spontaneously hypertensive rats].
    Ader JL; Praddaude F; Tran Van T
    J Physiol (Paris); 1986; 81(1):34-40. PubMed ID: 3639155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urinary kallikrein activity in conscious spontaneously-hypertensive rats: development as a function of age].
    Tran-Van T; Praddaude F; Ader JL
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1681-6. PubMed ID: 3938241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exaggerated natriuresis in the conscious spontaneously hypertensive rat.
    Willis LR; McCallum PW; Higgins JT
    J Lab Clin Med; 1976 Feb; 87(2):265-72. PubMed ID: 1245791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced urinary kallikrein excretion in response to a moderate sodium load in genetically hypertensive rats.
    Flückiger JP; Waeber B; Mimran A; Nussberger J; Wahba WK; Brunner HR
    J Cardiovasc Pharmacol; 1988; 12 Suppl 3():S36-42. PubMed ID: 2467104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of atrial natriuretic peptide (ANP) on the renal kallikrein-kinin system in normotensive and spontaneously hypertensive rats].
    Bönner G; Hirzel B; Ganten D; Kaufmann W
    Z Kardiol; 1988; 77 Suppl 2():85-91. PubMed ID: 2841816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary kallikrein in hypertensive animal models.
    Keiser HR; Geller RG; Margolius HS; Pisano JJ
    Fed Proc; 1976 Feb; 35(2):199-202. PubMed ID: 1248654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Normalization of active urinary kallikrein excretion by young spontaneously hypertensive rats by chronic inhibition of conversion enzyme].
    Tran-Van T; Praddaude F; Ader JL
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):857-63. PubMed ID: 3099701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man.
    Horwitz D; Margolius HS; Keiser HR
    J Clin Endocrinol Metab; 1978 Aug; 47(2):296-9. PubMed ID: 263797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced urinary kallikrein activity in rats developing spontaneous hypertension.
    Ader JL; Tran-Van T; Praddaude F
    Am J Physiol; 1987 Jun; 252(6 Pt 2):F964-9. PubMed ID: 3647733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in kallikrein excretion in spontaneously hypertensive rats.
    Ader JL; Pollock DM; Butterfield MI; Arendshorst WJ
    Am J Physiol; 1985 Mar; 248(3 Pt 2):F396-403. PubMed ID: 3844907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships among urinary kallikrein, mineralocorticoids and human hypertensive disease.
    Margolius HS; Horwitz D; Pisano JJ; Keiser HR
    Fed Proc; 1976 Feb; 35(2):203-6. PubMed ID: 1248655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary kallikrein response to acute saline or water loads in hypertensive and normal humans.
    Lawton WJ
    Hypertension; 1984; 6(2 Pt 1):175-83. PubMed ID: 6563013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary kallikrein excretion after potassium adaptation in the rat.
    Obika LF
    Arch Int Physiol Biochim; 1987 Sep; 95(3):189-93. PubMed ID: 2446581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ontogenic study of renal tissue kallikrein in Okamoto spontaneously hypertensive rats: comparisons with human hypertensive nephropathy.
    Figueroa CD; Bhoola KD; MacIver AG; Mackenzie JC
    Nephrol Dial Transplant; 1992; 7(6):516-25. PubMed ID: 1320231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of captopril on the urinary excretion of prostanoids and kallikrein in spontaneously hypertensive rats.
    Säynävälammi P
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):285-90. PubMed ID: 3541494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
    Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
    Clin Exp Hypertens (1978); 1980; 2(3-4):693-708. PubMed ID: 7000466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.